LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) Stock Price, Quote, News & History

SPY765.80+0.02%QQQ737.05+0.07%BTC/USD83,155.88−0.36%DIA514.14+0.02%GLD378.31+0.11%TLT78.69+0.09%

LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) Stock Price, Quote, News & History

LOBEFOTCQB

Trade with Public

$0.0535

0.00367.21%

At close: Sep 28, 5:00 PM EST

OverviewNews Financials Sentiment Compare

Key Statistics

Open

$0.05

Volume / Avg.

226.56K / 58.22K

Day Range

$0.05 - $0.05

52 Wk Range

0.02 - 0.11

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Lobe Sciences Ltd News

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

World's Largest Psychedelics Conference Boasts 12K Attendees

Lara Goldstein

This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches

Lobe Sciences Ltd. (OTCQB: LOBEF), a biopharmaceutical company focused on non-hallucinatory doses of stabilized psychedelic-based compounds to treat rare diseases, has commenced its Phase 1 clinical study on proprietary psilocin analog L-130.

Lara Goldstein

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a treatment of Major Depressive Disorder (MDD).

Lara Goldstein

Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up

Orphan and rare diseases drug company Lobe Sciences Ltd. (OTCQB: LOBEF) is set to acquire Altemia & Company LLC.

Lara Goldstein

Partner Content

Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!

As early as the 1950s, scientists were researching the possible therapeutic benefits of psychedelics such as LSD and psilocybin mushrooms.

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.74M

Investing Cash Flow (TTM)

-3.70M

Financing Cash Flow (TTM)

1.01M

Free Cash Flow (TTM)

-3.74M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-6.44M

Valuation Metrics

Enterprise Value

$12.90M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

11.53

Earnings Yield % (TTM)

-56.66%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

$338.40K

LT Debt

LT Debt Issuance (TTM)

-$11.37K

LT Debt Repayment (TTM)

Total Cash

$1.51M

Debt to Equity

0.18

Issuance of Debt (TTM)

-$11.37K

Repayment of Debt (TTM)

Key Statistics

Open

$0.05

Volume / Avg.

226.56K / 58.22K

Day Range

$0.05 - $0.05

52 Wk Range

0.02 - 0.11

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle c...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) stock?

You can purchase shares of LOBE SCIENCES LTD by LOBE SCIENCES LTD. (OTCQB:LOBEF) through any online brokerage.

View our list of the best stock brokerages

Who are LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) competitors?

There are no as such competitors for LOBE SCIENCES LTD by LOBE SCIENCES LTD..

What is the forecast, or price target, for LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) stock?

There is no analysis for LOBE SCIENCES LTD by LOBE SCIENCES LTD. to provide a consensus price target.

What is the current price for LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF)?

The stock price for LOBE SCIENCES LTD by LOBE SCIENCES LTD. (OTCQB: LOBEF) is $0.0535 last updated September 28, 2026 at 3:13 PM EDT.

Does LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) pay a dividend?

There are no upcoming dividends for LOBE SCIENCES LTD by LOBE SCIENCES LTD..

When is LOBE SCIENCES LTD by LOBE SCIENCES LTD. (OTCQB:LOBEF) reporting earnings?

LOBE SCIENCES LTD by LOBE SCIENCES LTD. does not have any upcoming earnings scheduled.

Is LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) going to split?

There is no upcoming split for LOBE SCIENCES LTD by LOBE SCIENCES LTD..

What sector and industry does LOBE SCIENCES LTD by LOBE SCIENCES LTD. (LOBEF) operate in?

LOBE SCIENCES LTD by LOBE SCIENCES LTD. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.